1118 related articles for article (PubMed ID: 28524659)
61. Synthesis, cytotoxicity, apoptosis and molecular docking studies of novel phenylbutyrate derivatives as potential anticancer agents.
Mostoufi A; Baghgoli R; Fereidoonnezhad M
Comput Biol Chem; 2019 Jun; 80():128-137. PubMed ID: 30952039
[TBL] [Abstract][Full Text] [Related]
62. Design, synthesis and biological evaluation of pyridin-3-yl pyrimidines as potent Bcr-Abl inhibitors.
Pan X; Dong J; Gao H; Wang F; Zhang Y; Wang S; Zhang J
Chem Biol Drug Des; 2014 May; 83(5):592-9. PubMed ID: 24330598
[TBL] [Abstract][Full Text] [Related]
63. Synthesis and Structure-Activity Relationship; Exploration of some Potent Anti-Cancer Phenyl Amidrazone Derivatives.
Habashneh AY; El-Abadelah MM; Bardaweel SK; Taha MO
Med Chem; 2018; 14(5):468-477. PubMed ID: 29205121
[TBL] [Abstract][Full Text] [Related]
64. Design, synthesis, anti-tumor activity, and molecular modeling of quinazoline and pyrido[2,3-d]pyrimidine derivatives targeting epidermal growth factor receptor.
Hou J; Wan S; Wang G; Zhang T; Li Z; Tian Y; Yu Y; Wu X; Zhang J
Eur J Med Chem; 2016 Aug; 118():276-89. PubMed ID: 27132165
[TBL] [Abstract][Full Text] [Related]
65. Design, synthesis, graph theoretical analysis and molecular modelling studies of novel substituted quinoline analogues as promising anti-breast cancer agents.
Dessai PG; Dessai SP; Dabholkar R; Pednekar P; Naik S; Mamledesai S; Gopal M; Pavadai P; Kumar BK; Murugesan S; Chandavarkar S; Theivendren P; Selvaraj K
Mol Divers; 2023 Aug; 27(4):1567-1586. PubMed ID: 35976550
[TBL] [Abstract][Full Text] [Related]
66. Chromone-embedded peptidomimetics and furopyrimidines as highly potent SARS-CoV-2 infection inhibitors: docking and MD simulation study.
Shakibay Senobari Z; Masoumian Hosseini M; Teimouri MB; Rezayan AH; Samarghandian S; Hekmat A
BMC Res Notes; 2023 Sep; 16(1):224. PubMed ID: 37735703
[TBL] [Abstract][Full Text] [Related]
67. Derivatives of D(-) glutamine-based MMP-2 inhibitors as an effective remedy for the management of chronic myeloid leukemia-Part-I: Synthesis, biological screening and in silico binding interaction analysis.
Das S; Mondal S; Patel T; Himaja A; Adhikari N; Banerjee S; Baidya SK; De AK; Gayen S; Ghosh B; Jha T
Eur J Med Chem; 2024 Aug; 274():116563. PubMed ID: 38843586
[TBL] [Abstract][Full Text] [Related]
68. Virtual discovery of a hetero-cyclic compound from the Universal Natural Product Database (UNPD36) as a potential inhibitor of interleukin-33: molecular docking and dynamic simulations.
Adamu RM; Singh RM; Ibrahim MA; Uba AI
J Biomol Struct Dyn; 2022; 40(19):8696-8705. PubMed ID: 33896389
[TBL] [Abstract][Full Text] [Related]
69. Investigating the potential of 6-substituted 3-formyl chromone derivatives as anti-diabetic agents using in silico methods.
Saif MZ; Esha NJI; Quayum ST; Rahman S; Al-Gawati MA; Alsowygh G; Albrithen H; Alodhayb AN; Poirier RA; Uddin KM
Sci Rep; 2024 Jun; 14(1):13221. PubMed ID: 38851807
[TBL] [Abstract][Full Text] [Related]
70. Molecular docking, QSAR, pharmacophore modeling, and dynamics studies of some chromone derivatives for the discovery of anti-breast cancer agents against hormone-dependent breast cancer.
Arvindekar SA; Mohole S; Patil A; Mane P; Arvindekar A; Mali SN; Thorat B; Rawat R; Sharma S
J Biomol Struct Dyn; 2023; 41(24):14757-14770. PubMed ID: 36995997
[TBL] [Abstract][Full Text] [Related]
71. Quantitative Structure-Cytotoxicity Relationship of 2-(
Shi H; Nagai J; Sakatsume T; Bandow K; Okudaira N; Sakagami H; Tomomura M; Tomomura A; Uesawa Y; Takao K; Sugita Y
Anticancer Res; 2018 Jul; 38(7):3897-3906. PubMed ID: 29970510
[TBL] [Abstract][Full Text] [Related]
72. Design, Synthesis, Anticancer Evaluation and Docking Studies of Novel Heterocyclic Derivatives Obtained via Reactions Involving Curcumin.
Borik RM; Fawzy NM; Abu-Bakr SM; Aly MS
Molecules; 2018 Jun; 23(6):. PubMed ID: 29890691
[TBL] [Abstract][Full Text] [Related]
73. Computational insight into the phthalocyanine-DNA binding via docking and molecular dynamics simulations.
Ozalp L; Sağ Erdem S; Yüce-Dursun B; Mutlu Ö; Özbil M
Comput Biol Chem; 2018 Dec; 77():87-96. PubMed ID: 30245350
[TBL] [Abstract][Full Text] [Related]
74. Identification of natural inhibitors of Bcr-Abl for the treatment of chronic myeloid leukemia.
Parcha P; Sarvagalla S; Madhuri B; Pajaniradje S; Baskaran V; Coumar MS; Rajasekaran B
Chem Biol Drug Des; 2017 Oct; 90(4):596-608. PubMed ID: 28338290
[TBL] [Abstract][Full Text] [Related]
75. Discovery of novel Bcr-Abl inhibitors with diacylated piperazine as the flexible linker.
Pan X; Dong J; Shi Y; Shao R; Wei F; Wang J; Zhang J
Org Biomol Chem; 2015 Jul; 13(25):7050-66. PubMed ID: 26052668
[TBL] [Abstract][Full Text] [Related]
76. Discovery of Substituted 2-oxoquinolinylthiazolidin-4-one Analogues as Potential EGFRK Inhibitors in Lung Cancer Treatment.
Naik S; Soumya V; Mamledesai SN; Manickavasagam M; Choudhari P; Rathod S
Drug Res (Stuttg); 2024 Jun; 74(5):227-240. PubMed ID: 38830371
[TBL] [Abstract][Full Text] [Related]
77. Synthesis, biological evaluation, QSAR and molecular dynamics simulation studies of potential fibroblast growth factor receptor 1 inhibitors for the treatment of gastric cancer.
Ying S; Du X; Fu W; Yun D; Chen L; Cai Y; Xu Q; Wu J; Li W; Liang G
Eur J Med Chem; 2017 Feb; 127():885-899. PubMed ID: 27829519
[TBL] [Abstract][Full Text] [Related]
78. Combined molecular dynamics and continuum solvent approaches (MM-PBSA/GBSA) to predict noscapinoid binding to γ-tubulin dimer.
Suri C; Naik PK
SAR QSAR Environ Res; 2015 Jun; 26(6):507-19. PubMed ID: 26274780
[TBL] [Abstract][Full Text] [Related]
79. Design, synthesis, and biological activity of Plastoquinone analogs as a new class of anticancer agents.
Bayrak N; Yıldırım H; Yıldız M; Radwan MO; Otsuka M; Fujita M; Tuyun AF; Ciftci HI
Bioorg Chem; 2019 Nov; 92():103255. PubMed ID: 31542717
[TBL] [Abstract][Full Text] [Related]
80. Design and synthesis of new RAF kinase-inhibiting antiproliferative quinoline derivatives. Part 2: Diarylurea derivatives.
El-Gamal MI; Khan MA; Tarazi H; Abdel-Maksoud MS; Gamal El-Din MM; Yoo KH; Oh CH
Eur J Med Chem; 2017 Feb; 127():413-423. PubMed ID: 28088086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
